NewsBenzingaNuvation Bio présentera des données mises à jour de son essai de phase 2 J201, ainsi que trois affiches sur les études en cours portant sur le safusidenib, lors de la réunion annuelle de la Society for Neuro-Oncology. Nuvation Bio présentera des données mises à jour de son essai de phase 2 J201, ainsi que trois affiches sur les études en cours portant sur le safusidenib, lors de la réunion annuelle de la Society for Neuro-Oncology. Benzinga 2026.11.02 13:06 (GMT+0) Open on Benzinga Other news Key Overnight and Morning News (Nov 17 – Nov 18) Bitcoin, Ethereum Dip, While XRP, Dogecoin Gain as US Launches 'Self-Defense' Strikes Against Iran: Analyst Asks BTC Investors to 'Endure' Next 2 Months of Pain Global robotics company Genesis AI closes $500M Series A at $3.5B post-money valuation Alphabet's AI Drug Discovery Firm Isomorphic Labs Completes $5B Series C Funding, Co-Led by Sequoia Capital and Others Bitcoin miner MARA continues selling, offloading another $121 million in BTC over the past 8 days Jeff Bezos Warns Outsider CEO Replacing Jensen Huang Faces ‘Vanishingly Small Chance of Succeeding’ at Nvidia: ‘Too Complicated’
Bitcoin, Ethereum Dip, While XRP, Dogecoin Gain as US Launches 'Self-Defense' Strikes Against Iran: Analyst Asks BTC Investors to 'Endure' Next 2 Months of Pain
Alphabet's AI Drug Discovery Firm Isomorphic Labs Completes $5B Series C Funding, Co-Led by Sequoia Capital and Others
Jeff Bezos Warns Outsider CEO Replacing Jensen Huang Faces ‘Vanishingly Small Chance of Succeeding’ at Nvidia: ‘Too Complicated’